Practo Competitive Intelligence & Landscape
practo.com ·
What is Practo likely to do next?
ForesightIQ connects Practo's hiring, product, web, ad, and market signals to forecast strategic moves — often months before they're announced.
Senior hiring patterns point to a planned enterprise product line launching within two quarters.
Quiet changes to docs and pricing pages signal an upcoming usage-based pricing tier and new API surface.
Ad spend and partnership activity indicate a push into the mid-market segment across two new regions.
Free · generated in ~60 seconds · no signup to preview
Overview
Practo Overview
Practo's target market spans over 22 countries, with a significant presence in India and recent expansion into the UAE, serving over 50 crore patients and connecting more than 5 lakh healthcare providers across 900 cities (Exa). Its services cater to both consumers seeking healthcare access and healthcare providers looking to digitize and optimize their practices. The company's mission is to simplify healthcare and empower individuals to make informed health decisions, leveraging data science and secure technology standards like HIPAA compliance and ISO 27001 certification (Exa).
With a workforce of approximately 858 employees and annual revenues around USD 24.6 million, Practo continues to grow rapidly, recently reporting a 90% improvement in EBITDA for FY24 and ongoing efforts to raise funds for future expansion, including a pre-IPO round (Exa). Its competitive edge lies in its comprehensive platform, security standards, and global reach, making it a prominent player in the health tech industry.
Sources
Practo | Video Consultation with Doctors, Book Doctor Appointments, Order Medicine, Diagnostic Tests
practo.com
Practo Digest
blog.practo.com
Frequently Asked Questions about Practo – Practo Help
help.practo.com
Practo - 2026 Company Profile, Team, Funding, Competitors & Financials - Tracxn
tracxn.com
Practo
in.linkedin.com
Competitors
Practo Competitors
Helium Health specializes in digital health tools and financing solutions for healthcare providers, primarily operating in Africa. Its key differentiator is its focus on digital health infrastructure and financing, positioning itself as a comprehensive health-tech platform that supports healthcare delivery and management (CB Insights). Compared to Practo, Helium Health emphasizes health system strengthening through technology and financing, rather than patient-facing services.
Zocdoc (mentioned in a related sector) is a prominent US-based platform that enables patients to book medical appointments online. Its market position is strengthened by its extensive network of healthcare providers and user-friendly interface, focusing on appointment management and telehealth services. Unlike Practo, Zocdoc primarily operates in the US and emphasizes appointment scheduling and patient reviews, with a competitive edge in user experience and provider network size (CB Insights).
Lybrate is an Indian digital health platform that connects patients with doctors for online consultations, health advice, and medicine delivery. It differentiates itself through its comprehensive health services, including health tips, online consultations, and a large network of doctors, making it a direct competitor in the Indian market. Compared to Practo, Lybrate emphasizes accessible telemedicine and health information, targeting a broad consumer base with a focus on affordability and ease of access (Ahrefs).
Yodawy (another competitor in the broader healthcare tech space) offers pharmacy and medicine delivery services, integrating with healthcare providers for medication management. Its market niche is in pharmacy logistics and medication adherence, complementing Practo’s broader healthcare management services but focusing more on supply chain and medication delivery solutions (CB Insights).
Sources
What is Competitive Landscape of Practo Company?
canvasbusinessmodel.com
Top practo.com competitors & alternatives - AhrefsTop
ahrefs.com
Top Practo Alternatives, Competitors
cbinsights.com
Practo: Revenue, Competitors, Alternatives
growjo.com
Top Vezeeta Alternatives, Competitors
cbinsights.com
BigOHealth — investment search application on «in.startup.network»
in.startup.network
Alternatives
Practo Alternatives
Product & Pricing
Practo Product and Pricing Intelligence
For telemedicine, Practo Prime provides high-quality doctor visits with no additional charge for patients, although consultation fees are paid to the doctors (Practo Help). The platform fee for Practo Prime Online was revised from 20% to 30% per connection in August 2022, reflecting industry growth and the need for enhanced platform services (Practo Help).
Additionally, Practo’s Ray Connect virtual assistant service offers plans starting at Rs. 999 per month for 1000 credits, with discounts available for longer-term commitments, aimed at improving clinic call management (Practo Help). Overall, Practo’s pricing structure combines subscription-based models, pay-per-use services, and tiered plans to cater to healthcare providers and patients, with recent updates emphasizing increased platform fees and expanded telehealth capabilities.
Sources
Practo Tab Subscription
help.practo.com
FAQs for Practo Prime – Patients
help.practo.com
Ray Connect Pricing & FAQs - Practo Help
help.practo.com
Prime Online – Price Revision – Practo Help
help.practo.com
Frequently Asked Questions about Practo – Practo Help
help.practo.com
FAQs for Practo Plus – Practo Help
help.practo.com
Hiring & Layoffs
Practo Hiring and Layoffs
In terms of hiring trends, there is limited specific data on recent new job openings, but the company's push into new markets and increased transaction volumes in categories like dental and mental health imply ongoing hiring to support expansion and product development (YourStory). Notably, in April 2023, Practo laid off 41 employees, mostly engineers, which indicates a possible restructuring phase to optimize costs or realign resources with strategic priorities (The Economic Times).
Overall, Practo's hiring patterns and recent layoffs suggest a company in a strategic transition—focusing on international market expansion and operational efficiency. This signals a shift toward consolidating its core strengths while exploring new growth avenues, which could lead to increased hiring in areas aligned with its international expansion and healthcare technology innovations.
Sources
Practo pushes into US healthcare market after early traction
yourstory.com
Indian healthcare platform Practo aims to double ...
reuters.com
Practo layoffs: Healthtech platform Practo lays off 41 employees, mostly engineers - The Economic Times
m.economictimes.com
7 AI Trends Every CTO Needs on Their Radar in 2026
linkedin.com
Leadership
Practo Management and Leadership Team
Recent leadership developments include the appointment of Cijo George as Vice President of AI in March 2026, tasked with advancing Practo’s AI strategy across care navigation and platform intelligence, reflecting the company's focus on AI-driven healthcare solutions (Result 5). Additionally, Shoumyan Biswas was appointed as the Global Chief Strategy and Marketing Officer in 2025, leading global expansion and customer engagement strategies (Result 6).
While specific details about the board members are limited, these recent executive hires and leadership changes highlight Practo’s strategic focus on AI, international growth, and digital health innovation.
Sources
Practo - 2026 Company Profile & Team - Tracxn
tracxn.com
Practo Strengthens AI Leadership With Cijo George Appointment
smestreet.in
Practo hires Shoumyan Biswas as global chief strategy and marketing officer
indianstartupnews.com
Shashank ND - Founder & CEO, Practo - LinkedIn
in.linkedin.com
Practo founders & board of directors
tracxn.com
Dr. Alexander Kuruvilla
theorg.com
Financials
Practo Financial Performance, Fundraising, M&A
Regarding fundraising, Practo has accumulated total funding of approximately ₹1,665.59 crore (around $200 million), although specific recent rounds are not detailed in the available sources. The company has also been actively expanding internationally, aiming to double its revenue from international markets within three years, with about 20% of its revenue currently coming from these regions (Reuters).
As for mergers and acquisitions, there are no specific recent M&A activities reported in the sources. However, Practo continues to focus on expanding its healthcare services and digital health solutions, leveraging its extensive user base of over 40 crore consumers and 5 lakh healthcare providers, which positions it as a leading player in the digital health space (Practo Blog). Overall, Practo's financial health appears robust, with a clear trajectory toward profitability and growth in both domestic and international markets.
Sources
FY25 Recap: A Year of Profitability, Progress, and Purpose
blog.practo.com
Indian healthcare platform Practo aims to double international ...
reuters.com
Practo Improves Health Outcomes for Millions While Achieving ...
blog.practo.com
10 Financial Metrics Every Healthcare CFO Must Master - FinThrive
finthrive.com
Practo Achieves Profitability While Transforming Healthcare For ...
bwhealthcareworld.com
Practo - 2026 Company Profile, Team, Funding, Competitors & Financials - Tracxn
tracxn.com
Practo - 2026 Funding Rounds & List of Investors - Tracxn
tracxn.com
Practo – Financial Information, Revenue, Profit/Loss, Expenses
thekredible.com
Partnerships
Practo Partnerships, Clients and Vendors
In terms of strategic acquisitions, Practo acquired Qikwell in 2015, a doctor appointment booking platform, to strengthen its service offerings and expand its reach within the healthcare ecosystem (YourStory). This acquisition helped Practo integrate more seamless appointment management and enhance its digital health services. Practo also maintains technology integrations with top clinics and hospitals, providing comprehensive telehealth and consultation services, which are accessible via its mobile app and online platform. These ecosystem relationships and partnerships position Practo as a key player in India's digital health landscape, with ongoing efforts to build an integrated health ecosystem (Tracxn).
Sources
Practo - 2026 Company Profile & Team - Tracxn
tracxn.com
Practo: Doctor Appointment App - Google Play
play.google.com
Practo raises $55M Series D funding from Tencent & others
economictimes.indiatimes.com
Practo on an acquisition spree, gets doctor appointment booking platform Qikwell on board
yourstory.com
Practo raises $55M Series D funding from Tencent & others
economictimes.indiatimes.com
Events
Practo Event Participations
Sources
Practo Hosts Webinar On India's Obesity Challenge: Gut Health's Crucial Role Unveiled
bwhealthcareworld.com
How to Create an Event
help.practo.com
Enhanced Consultations List on Practo Pro App – Feb'21
help.practo.com
Understanding the Patient Queue
help.practo.com
How to design better user experiences for physicians
dovetail.com
An Overview of Access Control
help.practo.com
Karnataka Ophthalmic Society Honours Practo for its Exemplary Contribution in Digital Healthcare at iBeach Festival 2019
bwhealthcareworld.com
Frequently Asked Questions
What does Practo's first sustained profitability in FY25 signal — genuine turnaround or a one-time inflection?
Practo's FY25 profitability looks like a structural turnaround rather than a one-time event: the company sustained positive EBITDA across six consecutive quarters, reaching operating EBITDA of ₹15 crore on ₹234 crore in revenue, compared to a ₹162 crore net loss in FY22. The GMV exceeding ₹3,500 crore suggests the underlying transaction engine is scaling, not just cost-cutting. That said, the EBITDA margin remains thin (~6%), so the turnaround is real but fragile — any aggressive international expansion spend could quickly reverse it.
What does the appointment of a VP of AI in March 2026 reveal about where Practo is placing its next product bets?
Bringing in Cijo George as Vice President of AI in March 2026, specifically tasked with care navigation and platform intelligence, signals that Practo is shifting from a directory/booking model toward an AI-driven clinical-decision and patient-routing layer. Combined with the earlier hire of Shoumyan Biswas as Global Chief Strategy and Marketing Officer to lead international expansion, the leadership build-out suggests Practo is betting that AI differentiation will be the wedge for both domestic upsell and international market entry, particularly in the US.
What does Practo's goal to double international revenue in three years imply about where it expects domestic growth to plateau?
Practo's explicit target to double international revenue over three years — with international currently representing roughly 20% of total revenue — implies management believes the Indian market alone cannot sustain the growth rate needed to justify a pre-IPO valuation. The early traction in the US market and the UAE presence suggest a two-geography international thesis rather than a broad multi-market scatter. For corp-dev analysts, this is a signal that Practo may be receptive to distribution partnerships or acquisitions in the US and Gulf markets to accelerate that timeline.
What did the April 2023 engineer layoffs of 41 employees tell us about Practo's cost structure priorities ahead of its profitability push?
The April 2023 layoffs — concentrated in engineering — indicate Practo was deliberately trimming R&D headcount to compress its cost base as it pushed toward EBITDA breakeven, which it achieved by FY25. This is consistent with a company consolidating its product surface area rather than building new features broadly. The fact that it then hired a VP of AI in 2026 suggests the restructuring phase is over and selective, high-value technical hiring has resumed, now oriented around AI rather than general engineering capacity.
Is Practo's platform fee increase from 20% to 30% per telemedicine connection a margin lever or a competitive risk?
The August 2022 revision of Practo Prime Online's platform fee from 20% to 30% is a meaningful margin lever — a 50% increase in take rate on every consultation — but it carries competitive risk in a market where Lybrate and other Indian telemedicine players compete on affordability. The move is consistent with Practo's path to EBITDA profitability achieved in FY25, suggesting the fee hike held without significant doctor or patient attrition. However, as Practo pushes into the US, where Zocdoc and others operate with different fee structures, pricing strategy will need to be reassessed market by market.
What does Practo's competitive set — Lybrate domestically and Zocdoc in the US — reveal about the strategic gaps it must close to win internationally?
Domestically, Lybrate competes with Practo on telemedicine and health information for price-sensitive consumers, meaning Practo's moat at home rests on its broader platform (practice management, diagnostics, pharmacy) rather than any single feature. In the US, Zocdoc's competitive edge is its provider network depth and user experience in appointment scheduling — an area where Practo is an early entrant without an established brand. Closing that gap in the US likely requires either a provider-network acquisition or a partnership-led go-to-market, rather than organic build, given the three-year revenue-doubling target.
What does Shashank ND's role as CII Subcommittee Chair on Digital Health signal about Practo's regulatory and policy positioning?
Shashank ND's chairmanship of the CII Subcommittee on Digital Health positions Practo as an active shaper of India's digital health policy environment, not merely a compliant participant. This is strategically valuable as India's National Digital Health Mission evolves — Practo gains early visibility into regulatory frameworks and can influence interoperability standards that would benefit its existing HIPAA- and ISO 27001-compliant infrastructure. For competitors, it means Practo has a structural early-warning advantage on policy shifts that could affect telemedicine pricing, data-sharing mandates, or licensing requirements.
What does Practo's Tencent-backed Series D and the absence of reported recent funding rounds suggest about its current capital strategy?
Practo's last clearly documented external funding was a $55 million Series D involving Tencent, and the company has accumulated approximately $200 million in total funding. The current narrative centers on a pre-IPO round rather than another venture round, which — combined with six consecutive quarters of positive EBITDA — suggests Practo is positioning for a public markets exit rather than further dilutive private financing. The absence of reported M&A activity in recent years further supports a capital-preservation posture ahead of a listing, though the international expansion ambition could trigger acquisitions if organic traction in the US proves slow.
What does Practo's webinar on India's obesity and gut health challenge in September 2025 signal about its content and category strategy?
Hosting a webinar on India's obesity and gut health challenge aligns with Practo's reported growth in non-traditional consultation categories — dental and mental health are cited as high-growth transaction segments. Obesity and metabolic health represent a large, underpenetrated chronic-care opportunity in India, and owning the awareness and education layer through webinars is a low-cost top-of-funnel strategy to drive consultations on the platform. This suggests Practo is deliberately expanding its clinical category footprint beyond acute-care bookings toward higher-frequency, higher-lifetime-value chronic condition management.
What does Practo's scale — 500,000 providers across 900 cities and 40+ crore consumers — mean for its defensibility against new entrants?
A network of 5 lakh healthcare providers and over 40 crore consumers across 900 Indian cities creates a significant supply-demand flywheel that is expensive for new entrants to replicate from scratch. The defensibility is strongest in Tier 2 and Tier 3 cities where digital health infrastructure is sparse and Practo's network effects are hardest to displace. However, the same scale creates a vulnerability: any major hospital chain or pharmacy network (e.g., Apollo, PharmEasy) that builds a competing integrated platform can simultaneously attack Practo's provider and consumer sides, making vertical integration by incumbents the primary competitive threat rather than pure-play startups.
What does Practo's Ray Connect virtual assistant pricing — starting at ₹999/month — reveal about its strategy for monetizing smaller clinics?
Ray Connect's entry price of ₹999 per month for 1,000 credits is deliberately low-friction, designed to onboard smaller, price-sensitive clinics onto Practo's practice management stack where switching costs then accumulate over time. This land-and-expand model — hardware (Practo Tab at ₹17,000 one-time) plus tiered SaaS subscriptions — mirrors playbooks used by practice management platforms globally to convert clinics from paper-based workflows into sticky digital dependencies. For competitive analysts, this means Practo's B2B revenue stream from provider software is structurally stickier than its B2C consultation marketplace, and is likely the more defensible earnings base as it approaches IPO.
Powered by ForesightIQ · Competitive intelligence from digital exhaust